Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 17701-17750 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT03252314
Ruptured Aneurysms Treated With Hydrogel Coils
N/AActive, not recruiting
1,000 participants
Started: Nov 27, 2017 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT03149029
Abbreviated MAPK Targeted Therapy Plus Pembrolizumab in Melanoma
PHASE2Active, not recruiting
16 participants
Started: Nov 27, 2017 · Completed: Dec 31, 2025
1 condition2 sponsors2 locations
NCT02984410
"Study Assessing The Best of Radiotherapy vs the Best of Surgery in Patients With Oropharyngeal Carcinoma"
NAActive, not recruiting
112 participants
Started: Nov 27, 2017 · Completed: Jun 30, 2029
3 conditions1 sponsor32 locations
NCT03267433
Rituximab With or Without Stem Cell Transplant in Treating Patients With Minimal Residual Disease-Negative Mantle Cell Lymphoma in First Complete Remission
PHASE3Active, not recruiting
689 participants
Started: Nov 27, 2017 · Completed: Jan 31, 2027
1 condition2 sponsors375 locations
NCT03376867
Reference Values and Clinical Screening Test of Diffuse Noxious Inhibitory Controls (DNIC)
N/AActive, not recruiting
468 participants
Started: Nov 27, 2017 · Completed: Dec 30, 2024
1 condition4 sponsors1 location
NCT03179943
Atezolizumab + Guadecitabine in Patients With Checkpoint Inhibitor Refractory or Resistant Urothelial Carcinoma
PHASE2Active, not recruiting
21 participants
Started: Nov 27, 2017 · Completed: Jul 31, 2022
1 condition3 sponsors3 locations
NCT03256981
Stereotactic Body Radiotherapy for the Treatment of OPD
PHASE2/PHASE3Active, not recruiting
113 participants
Started: Nov 27, 2017 · Completed: Jun 30, 2025
1 condition1 sponsor29 locations
NCT05067712
The Effect of Surgical Technique on PDC
NAActive, not recruiting
88 participants
Started: Nov 25, 2017 · Completed: Dec 31, 2024
1 condition2 sponsors2 locations
NCT03345173
Facilitating Rapid Naltrexone Initiation
PHASE3Active, not recruiting
100 participants
Started: Nov 25, 2017 · Completed: Oct 31, 2024
1 condition2 sponsors1 location
NCT03614689
Assessment of the Minimal Residual Disease in Ovarian Cancer From Circulating Tumor DNA and Immune Repertoire
N/AActive, not recruiting
104 participants
Started: Nov 25, 2017 · Completed: Dec 31, 2024
1 condition2 sponsors6 locations
NCT03332797
A Study of GDC-9545 Alone or in Combination With Palbociclib and/or Luteinizing Hormone-Releasing Hormone (LHRH) Agonist in Locally Advanced or Metastatic Estrogen Receptor-Positive Breast Cancer
PHASE1Active, not recruiting
181 participants
Started: Nov 24, 2017 · Completed: Jul 31, 2026
1 condition1 sponsor23 locations
NCT03360591
Functional Assessment in TAVI: FAITAVI
NAActive, not recruiting
320 participants
Started: Nov 24, 2017 · Completed: Jun 30, 2025
2 conditions1 sponsor1 location
NCT03236428
Phase II Study of the CD38 Antibody Daratumumab in Patients With High-Risk MGUS and Low-Risk Smoldering Multiple Myeloma
PHASE2Active, not recruiting
42 participants
Started: Nov 24, 2017 · Completed: Oct 4, 2026
2 conditions5 sponsors6 locations
NCT03141671
Randomized Phase II Study of Salvage XRT + ADT +/- Abiraterone and Apalutamide for Rising PSA After RP (FORMULA-509)
PHASE2Active, not recruiting
345 participants
Started: Nov 24, 2017 · Completed: Dec 31, 2025
1 condition2 sponsors8 locations
NCT03322072
Calypso Guided High Precision Stereotactic Ablative Radiosurgery for Lung TUmours Using Real-Time Tumour Tracking & Respiratory Gating
NAActive, not recruiting
28 participants
Started: Nov 23, 2017 · Completed: Jan 14, 2025
5 conditions2 sponsors2 locations
NCT03030261
Elotuzumab, Pomalidomide, & Dexamethasone (Elo-Pom-Dex) With Second Autologous Stem Cell Transplantation for Relapsed Multiple Myeloma
PHASE2Active, not recruiting
25 participants
Started: Nov 22, 2017 · Completed: Sep 26, 2027
1 condition3 sponsors3 locations
NCT03349385
Registry of Secondary Revascularization
N/AActive, not recruiting
869 participants
Started: Nov 22, 2017 · Completed: Dec 15, 2025
5 conditions3 sponsors1 location
NCT03356028
Pedopsychiatric and Multidisciplinary Research Devoted to Children Exposed to the Attack in Nice on July 14, 2016
NAActive, not recruiting
728 participants
Started: Nov 21, 2017 · Completed: Dec 31, 2044
2 conditions1 sponsor1 location
NCT03682029
Epigenetics, Vitamin C, and Abnormal Blood Cell Formation - Vitamin C in Patients With Low-Risk Myeloid Malignancies
NAActive, not recruiting
109 participants
Started: Nov 21, 2017 · Completed: Sep 27, 2025
3 conditions8 sponsors5 locations
NCT03352765
A Phase I Study of Bendamustine and Melphalan Conditioning and Autologous Stem Cell Transplantation for Treatment of Multiple Myeloma and Relapsed/Refractory B-cell Lymphoma in Elderly Patients
PHASE1Active, not recruiting
28 participants
Started: Nov 20, 2017 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT03344848
Early Feasibility Study of the Orion Visual Cortical Prosthesis System
NAActive, not recruiting
6 participants
Started: Nov 20, 2017 · Completed: Mar 31, 2025
1 condition2 sponsors2 locations
NCT03261206
Stopping Aminosalicylate Therapy in Inactive Crohn's Disease
PHASE4Active, not recruiting
334 participants
Started: Nov 20, 2017 · Completed: Jun 30, 2026
2 conditions2 sponsors46 locations
NCT03352258
Effect of Low Dose Radiotherapy on Brain Amyloidosis in the Treatment of Alzheimer's Disease
NAActive, not recruiting
20 participants
Started: Nov 17, 2017 · Completed: Dec 30, 2027
1 condition1 sponsor1 location
NCT03277547
Kidney Function in Sickle Cell Anemia
N/AActive, not recruiting
300 participants
Started: Nov 17, 2017 · Completed: Dec 1, 2025
2 conditions3 sponsors3 locations
NCT03625921
Transfemoral Powered Foot and Physical Therapy Study
NAActive, not recruiting
20 participants
Started: Nov 17, 2017 · Completed: Jan 14, 2026
2 conditions2 sponsors1 location
NCT05056207
PREVENT: PeRomEter Visualization to ENd Treatment-related Lymphedema
NAActive, not recruiting
260 participants
Started: Nov 17, 2017 · Completed: Nov 17, 2026
1 condition1 sponsor1 location
NCT02724579
Reduced Craniospinal Radiation Therapy and Chemotherapy in Treating Younger Patients With Newly Diagnosed WNT-Driven Medulloblastoma
PHASE2Active, not recruiting
45 participants
Started: Nov 17, 2017 · Completed: Jun 30, 2027
1 condition2 sponsors195 locations
NCT03227042
A Prospective Natural History Study of Mucopolysaccharidosis Type IIIB (MPS IIIB)
N/AActive, not recruiting
44 participants
Started: Nov 16, 2017 · Completed: Dec 31, 2025
1 condition1 sponsor9 locations
NCT03274492
A Study Comparing the Efficacy and Safety of Polatuzumab Vedotin With Rituximab-Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab-Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Diffuse Large B-Cell Lymphoma
PHASE3Active, not recruiting
1,000 participants
Started: Nov 16, 2017 · Completed: Jul 5, 2026
1 condition1 sponsor216 locations
NCT03201848
The Efficacy and Safety of Huaiqihuang Granule in Children With Chronic Primary Immune Thrombocytopenia
PHASE4Active, not recruiting
216 participants
Started: Nov 16, 2017 · Completed: Jun 30, 2024
1 condition2 sponsors14 locations
NCT03088059
Biomarker-based Study in R/M SCCHN
PHASE2Active, not recruiting
340 participants
Started: Nov 16, 2017 · Completed: Dec 31, 2025
1 condition1 sponsor36 locations
NCT03359954
Radiation Therapy Before Surgery in Treating Patients With Hormone Receptor Positive, HER2 Negative Breast Cancer
PHASE2Active, not recruiting
25 participants
Started: Nov 16, 2017 · Completed: Oct 31, 2027
4 conditions2 sponsors1 location
NCT03489239
Entecavir to TAF Switch
PHASE3Active, not recruiting
27 participants
Started: Nov 16, 2017 · Completed: Sep 16, 2020
1 condition2 sponsors1 location
NCT03480646
ProSTAR: A Study Evaluating CPI-1205 in Patients With Metastatic Castration Resistant Prostate Cancer
PHASE1/PHASE2Active, not recruiting
242 participants
Started: Nov 15, 2017 · Completed: Dec 31, 2021
1 condition1 sponsor41 locations
NCT03316053
Cell Marker Predictors in Barrett's Esophagus
N/AActive, not recruiting
25 participants
Started: Nov 15, 2017 · Completed: Dec 1, 2026
1 condition1 sponsor1 location
NCT03373903
Dose Finding Study to Determine if BEZ235 Alone or in Combination With RAD001 Decreases the Incidence of Respiratory Tract Infections in the Elderly
PHASE2Active, not recruiting
652 participants
Started: Nov 15, 2017 · Completed: Jul 31, 2018
1 condition1 sponsor1 location
NCT02813824
Effect of Chemoprevention by Low-dose Aspirin of New or Recurrent Colorectal Adenomas in Patients With Lynch Syndrome
PHASE3Active, not recruiting
852 participants
Started: Nov 14, 2017 · Completed: Dec 15, 2027
1 condition1 sponsor1 location
NCT03278782
Study of Pembrolizumab (MK-3475) in Combination With Romidepsin
PHASE1/PHASE2Active, not recruiting
39 participants
Started: Nov 14, 2017 · Completed: Jul 31, 2027
11 conditions2 sponsors1 location
NCT03291496
Microfluidic Assessment of Clinical Outcomes in Preterm Newborns
N/AActive, not recruiting
293 participants
Started: Nov 14, 2017 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT02473341
Gut-Liver Axis Modulation With IgG-Enriched Immunotherapy in Severe Alcohol-Associated Hepatitis
PHASE3Active, not recruiting
174 participants
Started: Nov 14, 2017 · Completed: Sep 1, 2025
1 condition1 sponsor5 locations
NCT03281902
Genetic Analysis in Blood and Tumor Samples From Patients With Advanced or Metastatic Estrogen Receptor Positive and HER2 Negative Breast Cancer Receiving Palbociclib and Endocrine Therapy
N/AActive, not recruiting
68 participants
Started: Nov 13, 2017 · Completed: Mar 4, 2026
9 conditions2 sponsors3 locations
NCT05589493
Hybrid PEEK-Acrylic Resin Prostheses and the All-on-4 Concept for Full-Arch Rehabilitation - Routine Group
NAActive, not recruiting
39 participants
Started: Nov 13, 2017 · Completed: Jul 31, 2026
1 condition2 sponsors1 location
NCT02737878
Reshaping the Path of Mild Cognitive Impairment by Refining Exercise Prescription
NAActive, not recruiting
216 participants
Started: Nov 13, 2017 · Completed: Jul 31, 2025
1 condition1 sponsor1 location
NCT03190525
Clinical Decision-making, Prognosis, Quality of Life and Satisfaction in Relapsed/Refractory Multiple Myeloma
N/AActive, not recruiting
530 participants
Started: Nov 13, 2017 · Completed: Dec 31, 2025
1 condition1 sponsor35 locations
NCT03277469
Optimizing Brachytherapy Application and Delivery With MRI Guidance for Gynecologic Cancer
NAActive, not recruiting
49 participants
Started: Nov 13, 2017 · Completed: Sep 15, 2027
1 condition2 sponsors1 location
NCT03173092
A Study of Ixazomib (NINLARO®) in Combination With Lenalidomide and Dexamethasone (IRD) for the Treatment of Participants With Multiple Myeloma (MM)
PHASE4Active, not recruiting
141 participants
Started: Nov 13, 2017 · Completed: Nov 30, 2026
1 condition1 sponsor21 locations
NCT03306121
TPF+CCRT vs.CCRT+PF in High Risk Nasopharyngeal Carcinoma
PHASE3Active, not recruiting
322 participants
Started: Nov 13, 2017 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT03351803
BRCA Founder OutReach (BFOR) Study
N/AActive, not recruiting
5,412 participants
Started: Nov 10, 2017 · Completed: May 10, 2026
2 conditions9 sponsors5 locations
NCT03425838
Endocrine Therapy Plus CDK4/6 in First or Second Line for Hormone (SONIA) Receptor Positive Advanced Breast Cancer
PHASE3Active, not recruiting
1,050 participants
Started: Nov 9, 2017 · Completed: Dec 31, 2025
1 condition1 sponsor72 locations
NCT03306862
Effect of Peas in Soup on Blood Glucose Control
NAActive, not recruiting
24 participants
Started: Nov 8, 2017 · Completed: Jan 31, 2025
1 condition3 sponsors1 location